3/12
08:12 am
whwk
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights [Yahoo! Finance]
Low
Report
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights [Yahoo! Finance]
3/12
08:00 am
whwk
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
Low
Report
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
3/10
02:08 pm
whwk
Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027 [Yahoo! Finance]
Low
Report
Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027 [Yahoo! Finance]
2/26
08:19 am
whwk
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/26
08:00 am
whwk
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
2/25
02:51 pm
whwk
Aadi Bioscience Conference: CEO Spotlights Whitehawk ADC Pipeline, Cash Runway Through 2028 [Yahoo! Finance]
Low
Report
Aadi Bioscience Conference: CEO Spotlights Whitehawk ADC Pipeline, Cash Runway Through 2028 [Yahoo! Finance]
2/18
08:00 am
whwk
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Medium
Report
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
2/5
10:00 am
whwk
Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $6.00 price target on the stock.
Medium
Report
Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $6.00 price target on the stock.
1/8
08:00 am
whwk
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
Low
Report
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
12/30
04:16 pm
whwk
Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/22
01:38 pm
whwk
Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by analysts at Jones Trading. They set a "buy" rating and a $7.00 price target on the stock.
Low
Report
Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by analysts at Jones Trading. They set a "buy" rating and a $7.00 price target on the stock.
12/16
04:43 pm
whwk
Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.